Literature DB >> 3774124

The spinal cord as a major site for the antinociceptive action of nicotine in the rat.

M D Aceto, R S Bagley, W L Dewey, T C Fu, B R Martin.   

Abstract

These studies were conducted to localize the antinociceptive action of nicotine within the CNS. Antinociceptive and biodispositional studies were carried out after the injection of [3H]nicotine subcutaneously and intracerebroventricularly into the common carotid and vertebral arteries and into the subarachnoid space. The data indicated that [3H]nicotine was most potent when given into the subarachnoid space than by any of the other route of administration. Further, the disposition studies showed that [3H]nicotine was almost entirely contained in the thoracic and lumbar areas. These results are consistent with the hypothesis that the spinal cord is an important site for antinociception induced by nicotine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3774124     DOI: 10.1016/0028-3908(86)90198-x

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  13 in total

1.  Behavioral modulation of neuronal calcium/calmodulin-dependent protein kinase II activity: differential effects on nicotine-induced spinal and supraspinal antinociception in mice.

Authors:  M Imad Damaj
Journal:  Biochem Pharmacol       Date:  2007-07-10       Impact factor: 5.858

2.  Antinociceptive effect of chronic nicotine and nociceptive effect of its withdrawal measured by hot-plate and tail-flick in rats.

Authors:  C Y Yang; W H Wu; V K Zbuzek
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist.

Authors:  M I Damaj; K R Creasy; S P Welch; J A Rosecrans; M D Aceto; B R Martin
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

4.  Different methods of assessing nicotine-induced antinociception may engage different neural mechanisms.

Authors:  A R Caggiula; L H Epstein; K A Perkins; S Saylor
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

Review 5.  The potential application of nicotinic acetylcholine receptor agonists for the treatment of rheumatoid arthritis.

Authors:  Peng Zhang; Ling Qin; Ge Zhang
Journal:  Inflamm Res       Date:  2010-01-29       Impact factor: 4.575

Review 6.  Pain, nicotine, and smoking: research findings and mechanistic considerations.

Authors:  Joseph W Ditre; Thomas H Brandon; Emily L Zale; Mary M Meagher
Journal:  Psychol Bull       Date:  2011-11       Impact factor: 17.737

7.  The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.

Authors:  Shakir D AlSharari; F Ivy Carroll; J Michael McIntosh; M Imad Damaj
Journal:  J Pharmacol Exp Ther       Date:  2012-06-07       Impact factor: 4.030

8.  Behavioral effects after intrathecal administration of cholinergic receptor agonists in the rat.

Authors:  P G Gillberg; P Hartvig; T Gordh; A Sottile; I Jansson; T Archer; C Post
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Depression by nicotine of pain-related nociceptive activity in the rat thalamus and spinal cord.

Authors:  I Jurna; P Krauss; J Baldauf
Journal:  Clin Investig       Date:  1993-12

10.  Persistent smoking after a diagnosis of lung cancer is associated with higher reported pain levels.

Authors:  Marcella Daniel; Francis J Keefe; Pauline Lyna; Bercedis Peterson; Jennifer Garst; Mike Kelley; Gerold Bepler; Lori A Bastian
Journal:  J Pain       Date:  2009-03       Impact factor: 5.820

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.